277 related articles for article (PubMed ID: 25588356)
1. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease.
Magen I; Torres ER; Dinh D; Chung A; Masliah E; Chesselet MF
J Parkinsons Dis; 2015; 5(3):669-680. PubMed ID: 25588356
[TBL] [Abstract][Full Text] [Related]
2. Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.
Grant LM; Richter F; Miller JE; White SA; Fox CM; Zhu C; Chesselet MF; Ciucci MR
Behav Neurosci; 2014 Apr; 128(2):110-21. PubMed ID: 24773432
[TBL] [Abstract][Full Text] [Related]
3. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
Fleming SM; Tetreault NA; Mulligan CK; Hutson CB; Masliah E; Chesselet MF
Eur J Neurosci; 2008 Jul; 28(2):247-56. PubMed ID: 18702696
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.
Fleming SM; Salcedo J; Hutson CB; Rockenstein E; Masliah E; Levine MS; Chesselet MF
Neuroscience; 2006 Nov; 142(4):1245-53. PubMed ID: 16934409
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.
Magen I; Fleming SM; Zhu C; Garcia EC; Cardiff KM; Dinh D; De La Rosa K; Sanchez M; Torres ER; Masliah E; Jentsch JD; Chesselet MF
Eur J Neurosci; 2012 Mar; 35(6):870-82. PubMed ID: 22356593
[TBL] [Abstract][Full Text] [Related]
6. Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.
Subramaniam SR; Magen I; Bove N; Zhu C; Lemesre V; Dutta G; Elias CJ; Lester HA; Chesselet MF
Neurobiol Dis; 2018 Sep; 117():170-180. PubMed ID: 29859873
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Carnosine Mitigates α-Synuclein Pathology and Motor Dysfunction in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Brown JM; Baker LS; Seroogy KB; Genter MB
ACS Chem Neurosci; 2021 Jul; 12(13):2347-2359. PubMed ID: 34138535
[TBL] [Abstract][Full Text] [Related]
8. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
[TBL] [Abstract][Full Text] [Related]
9. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.
Gerstenberger J; Bauer A; Helmschrodt C; Richter A; Richter F
Behav Brain Res; 2016 May; 304():102-10. PubMed ID: 26880341
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
Torres ERS; Stanojlovic M; Zelikowsky M; Bonsberger J; Hean S; Mulligan C; Baldauf L; Fleming S; Masliah E; Chesselet MF; Fanselow MS; Richter F
Neurobiol Dis; 2021 Oct; 158():105478. PubMed ID: 34390837
[TBL] [Abstract][Full Text] [Related]
11. A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice.
Richter F; Stanojlovic M; Käufer C; Gericke B; Feja M
Neurotherapeutics; 2023 Jan; 20(1):97-116. PubMed ID: 36715870
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease.
Bermúdez ML; Seroogy KB; Genter MB
Neuroscience; 2019 Jul; 411():270-278. PubMed ID: 31125602
[TBL] [Abstract][Full Text] [Related]
13. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.
Wang L; Magen I; Yuan PQ; Subramaniam SR; Richter F; Chesselet MF; Taché Y
Neurogastroenterol Motil; 2012 Sep; 24(9):e425-36. PubMed ID: 22779732
[TBL] [Abstract][Full Text] [Related]
14. Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein.
McDowell KA; Shin D; Roos KP; Chesselet MF
J Parkinsons Dis; 2014; 4(3):531-539. PubMed ID: 24867919
[TBL] [Abstract][Full Text] [Related]
15. Intranasal carnosine attenuates transcriptomic alterations and improves mitochondrial function in the Thy1-aSyn mouse model of Parkinson's disease.
Bermúdez ML; Skelton MR; Genter MB
Mol Genet Metab; 2018 Nov; 125(3):305-313. PubMed ID: 30146452
[TBL] [Abstract][Full Text] [Related]
16. Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
Rabl R; Breitschaedel C; Flunkert S; Duller S; Amschl D; Neddens J; Niederkofler V; Rockenstein E; Masliah E; Roemer H; Hutter-Paier B
BMC Neurosci; 2017 Jan; 18(1):22. PubMed ID: 28143405
[TBL] [Abstract][Full Text] [Related]
17. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.
Fleming SM; Mulligan CK; Richter F; Mortazavi F; Lemesre V; Frias C; Zhu C; Stewart A; Gozes I; Morimoto B; Chesselet MF
Mol Cell Neurosci; 2011 Mar; 46(3):597-606. PubMed ID: 21193046
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice.
Cuvelier E; Méquinion M; Leghay C; Sibran W; Stievenard A; Sarchione A; Bonte MA; Vanbesien-Mailliot C; Viltart O; Saitoski K; Caron E; Labarthe A; Comptdaer T; Semaille P; Carrié H; Mutez E; Gressier B; Destée A; Chartier-Harlin MC; Belarbi K
Front Mol Neurosci; 2018; 11():321. PubMed ID: 30333721
[TBL] [Abstract][Full Text] [Related]
19. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
[TBL] [Abstract][Full Text] [Related]
20. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
